Published in Lancet on September 29, 1979
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine. Br Med J (1980) 1.09
Rubella vaccination: remaining problems. Br Med J (Clin Res Ed) (1982) 1.02
Outcome of pregnancy in a rubella outbreak in Northern Ireland 1978-1979. Ulster Med J (1984) 0.75
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
Hepatitis A. BMJ (1991) 3.77
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Liver disease among homosexual males. Lancet (1979) 2.74
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J Clin Microbiol (1993) 2.45
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol (1986) 2.21
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Hepatitis B infections after gynaecological surgery. Lancet (1989) 1.99
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85
Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ (1999) 1.79
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J Virol Methods (1994) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59
Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing? Ann R Coll Surg Engl (1996) 1.58
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children. J Med Virol (1983) 1.57
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet (1980) 1.54
Herpes genitalis; clinical and virological studies. Br J Vener Dis (1967) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40
Letter: Polio vaccination for travellers. Br Med J (1975) 1.39
Measles must go and with it rubella. Br Med J (Clin Res Ed) (1987) 1.38
Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38
Veterinary nursing examinations. Vet Rec (1994) 1.38
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30
Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26
New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26
Hepatitis A antibodies in London blood donors, medical students, and patients. Lancet (1980) 1.24
Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis (1999) 1.23
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol (1990) 1.22
A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods (1984) 1.21
Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur J Immunol (1997) 1.21
Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol (1987) 1.20
Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet (1989) 1.19
Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Willingness of homosexual and bisexual men in London to be screened for human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.16
Patients with suspected Lassa fever in London during 1984: problems in their management at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.14
A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Lond) (1967) 1.14
Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications. Can Med Assoc J (1966) 1.12
Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol (1995) 1.12
Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. J Gen Virol (1989) 1.11